| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.820 | 116.736 | 79.436 | 75.845 | 77.286 | 0 | 59.938 | 486.667 | 667.138 | 904.650 |
| Total Income - EUR | 258.535 | 337.018 | 268.699 | 176.089 | 1.047.559 | 154.866 | 131.720 | 1.054.013 | 1.093.854 | 3.895.940 |
| Total Expenses - EUR | 289.411 | 224.824 | 182.334 | 75.045 | 808.142 | 138.066 | 100.872 | 580.634 | 817.613 | 3.722.501 |
| Gross Profit/Loss - EUR | -30.876 | 112.194 | 86.365 | 101.044 | 239.418 | 16.800 | 30.848 | 473.379 | 276.241 | 173.439 |
| Net Profit/Loss - EUR | -30.876 | 111.391 | 78.467 | 98.670 | 229.672 | 16.250 | 29.765 | 468.438 | 239.463 | 144.266 |
| Employees | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 13 |
Check the financial reports for the company - Genesis Biopartner Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.118.885 | 3.477.101 | 3.252.945 | 3.186.706 | 2.125.491 | 2.914.980 | 2.894.073 | 2.824.929 | 9.477.548 | 18.017.666 |
| Current Assets | 37.906 | 78.699 | 44.036 | 47.286 | 350.345 | 748.879 | 144.873 | 502.765 | 552.608 | 336.255 |
| Inventories | 0 | 0 | 0 | 480 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14.522 | 44.828 | 5.387 | 4.833 | 346.447 | 105.607 | 75.099 | 379.409 | 535.336 | 94.573 |
| Cash | 23.384 | 33.871 | 38.649 | 41.973 | 3.899 | 643.272 | 69.774 | 1.689 | 17.273 | 10.276 |
| Shareholders Funds | 1.116.764 | 1.216.766 | 1.274.643 | 1.349.920 | 394.433 | 142.364 | 168.971 | 637.934 | 572.217 | 713.285 |
| Social Capital | 1.349.831 | 1.336.065 | 1.313.456 | 1.289.352 | 105.365 | 103.368 | 101.075 | 101.389 | 101.082 | 100.517 |
| Debts | 2.040.495 | 2.339.589 | 2.022.338 | 1.884.071 | 2.081.403 | 3.521.495 | 2.869.975 | 2.689.760 | 9.450.115 | 17.641.981 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6421 - 6421" | |||||||||
| CAEN Financial Year |
6420
|
|||||||||
Comments - Genesis Biopartner Srl